Principal Financial Group Inc. Cuts Stock Position in Corteva, Inc. $CTVA

Principal Financial Group Inc. lessened its stake in Corteva, Inc. (NYSE:CTVA) by 20.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,383,744 shares of the company’s stock after selling 850,579 shares during the period. Principal Financial Group Inc.’s holdings in Corteva were worth $226,812,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Activest Wealth Management grew its holdings in Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after purchasing an additional 200 shares during the last quarter. JPL Wealth Management LLC purchased a new position in Corteva in the third quarter worth $25,000. Redmont Wealth Advisors LLC purchased a new position in Corteva in the third quarter worth $29,000. Jackson Grant Investment Advisers Inc. grew its holdings in Corteva by 90.6% in the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after purchasing an additional 213 shares during the last quarter. Finally, Salomon & Ludwin LLC grew its holdings in Corteva by 183.6% in the third quarter. Salomon & Ludwin LLC now owns 485 shares of the company’s stock worth $31,000 after purchasing an additional 314 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Insider Buying and Selling

In other Corteva news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.15% of the company’s stock.

Corteva Price Performance

Shares of NYSE CTVA opened at $83.91 on Wednesday. The business’s 50 day moving average price is $80.55 and its 200 day moving average price is $72.34. The firm has a market cap of $56.33 billion, a P/E ratio of 53.11, a P/E/G ratio of 2.80 and a beta of 0.59. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $85.63. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.Corteva’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts expect that Corteva, Inc. will post 3.62 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio is presently 45.57%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Wall Street Zen downgraded shares of Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Wells Fargo & Company upped their price objective on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a report on Tuesday, April 21st. BNP Paribas Exane upped their price objective on shares of Corteva from $72.00 to $74.00 in a report on Monday, March 9th. Royal Bank Of Canada upped their price objective on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a report on Friday, April 24th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Corteva in a report on Wednesday, April 22nd. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat, Corteva currently has an average rating of “Moderate Buy” and a consensus price target of $86.38.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.